Raphael Pharmaceutical Inc. (RAPH)
About Raphael Pharmaceutical Inc.
RAPHAEL PHARMACEUTICL INC
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$1.3M
- Total assets
- $53.0K
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Raphael Pharmaceutical Inc. (RAPH) Stock Price
- Reported a net loss of $1.3M.
- Trading near its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Raphael Pharmaceutical Inc..
Write a review
News about Raphael Pharmaceutical Inc.
News & sentiment via Polygon.io
Raphael Pharmaceutical Inc.: frequently asked questions
Is Raphael Pharmaceutical Inc. an American company?
Raphael Pharmaceutical Inc. is a US-based company headquartered in Las Vegas, Nevada, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Raphael Pharmaceutical Inc. headquartered?
Raphael Pharmaceutical Inc. is headquartered in Las Vegas, Nevada, United States.
Is Raphael Pharmaceutical Inc. publicly traded?
Yes — Raphael Pharmaceutical Inc. is a publicly traded company. Its stock trades under the ticker symbol RAPH on the OTC.
What does Raphael Pharmaceutical Inc. do?
Raphael Pharmaceutical Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
